Drug
calcined magnesia
calcined magnesia is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
25%
Ph phase_3
2
50%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese Patients
NCT06950138
unknownnot_applicable
Effect of Cassia Cinnamon on Arterial Stiffness Parameters in Patients With Type 2 Diabetes Mellitus
NCT04259606
completedphase_3
Acetylsalicylic Acid and Type 2 Diabetes Mellitus
NCT03341117
completedphase_2
Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy
NCT02129231
Clinical Trials (4)
Showing 4 of 4 trials
NCT06950138Phase 3
Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese Patients
NCT04259606Not Applicable
Effect of Cassia Cinnamon on Arterial Stiffness Parameters in Patients With Type 2 Diabetes Mellitus
NCT03341117Phase 3
Acetylsalicylic Acid and Type 2 Diabetes Mellitus
NCT02129231Phase 2
Statins for Oxidative Stress and Mitochondrial Function in Diabetic Polyneuropathy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4